UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

Social media can play a critical role in advancing knowledge of rare and orphan diseases
Shazia Ahmad, Director, Patient & Physician Services - October 02, 2017
The growth of social media interactions has played a critical role in advancing knowledge and awareness of rare and orphan diseases. Social media tools have helped stakeholders working in rare disease clinical development to increase...
UBC's home care nurses play a critical role in rare disease clinical trials
- September 20, 2017
UBC was contracted to provide clinical trial nursing services in a pivotal Phase III rare autoimmune disease trial. As this indication affects less than 2% of the population, ensuring that enrolled patients completed study...
Exploring industry changes leading to the focus on real-world evidence
- September 14, 2017
While the term is nothing new, the focus on the topic of real-world evidence is suddenly reaching a fever pitch, and that’s understandable. Demands from payers, patients, prescribers, and regulators for definitive data have never been...
The DIA topic everyone is talking about
- September 08, 2017
While it’s been three months since we gathered with other healthcare professionals at DIA, the largest, longest-running event in the life sciences industry, there’s one topic everyone’s still talking about. Annette Stemhagen, DrPH,...
UBC's clinical research teams excel at speed, flexibility and collaboration
Vaishali Patil, Clinical Research Project Manager - August 17, 2017
For patients with a serious condition or immediately life-threatening disease who cannot participate in a controlled clinical trial, expanded access programs (EAPs) make investigational new drugs (INDs) available, under certain...

Pages